This article explores the following key points:
- Pfizer windfall (profits).
- Auth shortcuts/side effects.
- Global distribution inequalities (Gates).
- Expert biases in approvals.
- Fiat taxpayer rollout funding.
This article explores the following key points:
Leave a Reply